Driehaus Capital Management LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 938206 Chicago, IL

Position in ARQT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$52,445,243

-$21,968,159 QoQ

Shares Held

2,226,029

-13.1% QoQ

Ownership

1.78%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 76.7957650147415.ToString("F0")% Shared 0.ToString("F0")% None 23.204234985258505.ToString("F0")%

Healthcare · as of Mar 31, 2026

Driehaus Capital Management LLC holds $2,981,444,927 across 55 Biotechnology names. ARQT ranks #20 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	949,225	$305,830,802
2	XENE	Xenon Pharmaceuticals Inc.	4,491,653	$261,189,621
3	CRNX	Crinetics Pharmaceuticals, Inc.	6,395,922	$232,299,887
4	APGE	Apogee Therapeutics, Inc.	1,920,800	$161,673,736
5	EWTX	Edgewise Therapeutics, Inc.	4,477,942	$141,055,173
6	SYRE	Spyre Therapeutics, Inc.	2,790,785	$140,767,195
7	DFTX	Definium Therapeutics, Inc.	5,911,889	$111,734,702
8	SEPN	Septerna, Inc.	4,395,572	$105,625,595

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$52,445,243	2,226,029	-13.1%	Shares	Sole	2026-05-15
2025-12-31	$74,413,402	2,562,445	+133.6%	Shares	Sole	2026-02-17
2025-09-30	$20,678,525	1,097,004	+1.0%	Shares	Sole	2025-11-14
2025-06-30	$15,225,075	1,085,954	-0.6%	Shares	Sole	2025-08-14
2025-03-31	$17,090,375	1,092,735	-0.4%	Shares	Sole	2025-05-15
2024-12-31	$15,277,992	1,096,769	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.